Vifor Pharma AG
F:G2AB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vifor Pharma AG
F:G2AB
|
CH |
|
C
|
Cirtek Holdings Philippines Corp
XPHS:TECH
|
PH |
|
dotDigital Group PLC
OTC:DOTDF
|
UK |
|
S
|
Shandong Weigao Group Medical Polymer Co Ltd
XMUN:UK2
|
CN |
|
Redcare Pharmacy NV
F:SAE1
|
NL |
|
X
|
XL Axiata Tbk PT
XMUN:E5F
|
ID |
|
C
|
Centrica PLC
OTC:CPYYF
|
UK |
|
Getty Realty Corp
F:GRL
|
US |
|
S
|
Stratasys Ltd
F:SCY
|
US |
|
K
|
Kikkoman Corp
F:KIK
|
JP |
|
Indivior PLC
LSE:INDV
|
UK |
|
TalkPool AG
F:TKPL
|
CH |
|
M
|
Murphy Usa Inc
XBER:1MU
|
US |
|
C
|
Canadian Solar Inc
XMUN:L5A
|
CA |
|
Loandepot Inc
F:LDD
|
US |
|
T
|
Toho Titanium Co Ltd
F:40A
|
JP |
|
Cogeco Inc
F:76E
|
CA |
|
Aeva Technologies Inc
NASDAQ:AEVA
|
US |
|
A
|
Asia Sermkij Leasing PCL
SET:ASK
|
TH |
|
Sensus Healthcare Inc
F:5TX
|
US |
|
S
|
Samsung Heavy Industries Co Ltd
KRX:010145
|
KR |
Bankruptcy Probability
Vifor Pharma AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vifor Pharma AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH |
V
|
Vifor Pharma AG
SIX:VIFN
|
10.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vifor Pharma AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vifor Pharma AG has total debt of 117m CHF. This includes both short-term (0 CHF) and long-term (117m CHF) debt.
You can find a full breakdown on its Balance Sheet.
